GSK announced partial success in its late-stage ovarian cancer trials, where their drug Jemperli showed improved outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback